121671-81-6

Basic information

• Product Name: 5-(tert-butyldiphenylsilyloxy)-hexan-1-ol
• Synonyms: 5-(tert-butyldiphenylsilyloxy)-hexan-1-ol
• CAS NO: 121671-81-6
• Molecular Weight: 356.58
• Mol File: 121671-81-6.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: 5-(tert-butyldiphenylsilyloxy)-hexan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(tert-butyldiphenylsilyloxy)-hexan-1-ol(121671-81-6)
• EPA Substance Registry System: 5-(tert-butyldiphenylsilyloxy)-hexan-1-ol(121671-81-6)

Safety Data

• Hazardous Substances Data: 121671-81-6(Hazardous Substances Data)

Upstream product

• 121671-74-7 1-(tert-butyldimethylsilyloxy)-5-(tert-butyldiphenylsilyloxy)hexane 
• 626-94-8 (S)-5-hexen-2-ol 
• 207795-48-0 1-((hex-5-en-1-yloxy)methyl)-4-methoxybenzene 
• 821-41-0 5-Hexen-1-ol 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 191283-01-9 tert-Butyl-((S)-4-[1,3]dioxan-2-yl-1-methyl-butoxy)-diphenyl-silane 
• 185749-17-1 (5S)-5-(tert-butyldiphenylsilyloxy)hexanal 
• 185749-15-9 ((S)-5-Benzyloxy-1-methyl-pentyloxy)-tert-butyl-diphenyl-silane 
• 110065-99-1 tert-Butyl-[(S)-1-methyl-5-(tetrahydro-pyran-2-yloxy)-pentyloxy]-diphenyl-silane 
• 195875-25-3 (R)-ethyl 5-hydroxyhexanoate 
• 643016-60-8 (2R)-6-[(4-methoxybenzyl)oxy]hexan-2-ol 
• 131375-69-4 5-((4-methoxybenzyl)oxy)pentanal 
• 131375-63-8 5-(4-methoxybenzyloxy)-1-pentanol 
• 111-29-5 1 ,5-pentanediol 

Downstream Products

• 238403-76-4 5-(tert-butyldiphenylsilyloxy)-1-iodohexane 
• 238403-78-6 12-(t-butyldiphenylsilyloxy)-6-oxotridec-4-enal 
• 238403-79-7 15-(t-butyldiphenylsilyloxy)-2,9-dioxohexadeca-3,7-diene 
• 238403-77-5 8-(tert-butyl-diphenyl-silanyloxy)-1-(triphenyl-λ⁵-phosphanylidene)-nonan-2-one 
• 1372676-89-5 5-(tert-butyldiphenylsiloxy)hexanal 
• 1333419-89-8 (10R)-10-[1-(tert-butyl)-1,1-diphenylsilyl]oxy-1-undecen-6-ol 
• 1333419-90-1 tert-butyl[(1R)-1-methyl-5-(tetrahydro-2H-2-pyranyloxy)-9-decenyl]oxydiphenylsilane 
• 1333419-91-2 (1S)-1-methyl-5-(tetrahydro-2H-2-pyranyloxy)-9-decenyl 2,4-dimethoxy-6-vinylbenzoate 
• 1333419-92-3 (1S)-5-hydroxy-1-methyl-9-decenyl 2,4-dimethoxy-6-vinylbenzoate 
• 10497-40-2 2,4-Dimethoxy-zearalenone 
• 17924-92-4 zearalenone 
• 1388144-81-7 (R,E)-ethyl 7-tert-butyldiphenylsilanyloxyoct-2-enoate 
• 1388144-82-8 (2S,3R,7R)-ethyl 2,3-dihydroxy-7-(tert-butyldiphenylsilanyloxy)octanoate 
• 1388144-83-9 (4S,5R)-ethyl-5-((R)-4-(tert-butyldiphenylsilanyloxy)pentyl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate 

Relevant articles and documents

20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE

The present invention concerns compounds and their use to treat cardiovascular disease, renal disease, thrombic disease, stroke, metabolic syndrome, cell proliferation, and ischemic cardiovascular disorders. Compounds of the present invention display sign

Total synthesis of two γ-butyrolactone containing compounds (Z,11S)-3,4-trans-11-hydroxy-3-methyldodec-cis-6-en-4-olide and (Z)-3,4-trans-11-oxo-3-methyldodec-cis-6-en-4-olide

The first total synthesis of (Z,11S)-3,4-trans-11-hydroxy-3-methyldodec-cis-6-en-4-olide and (Z)-3,4-trans-11-oxo-3-methyldodec-cis-6-en-4-olide was accomplished using Jacobsen hydrolytic kinetic resolution, Ohira-Bestmann reaction, regioselective alkyne

First stereoselective total synthesis of naturally occurring (6 R)-6-(4-Oxopentyl)-5,6-dihydro-2 H -pyran-2-one and Its (6 S)-enantiomer

(6R)-6-(4-Oxopentyl)-5,6-dihydro-2H-pyran-2-one, a naturally occurring ,-unsaturated -lactone, and its (6S)-enantiomer have been synthesized stereoselectively starting from pentane-1,5-diol. The synthesis involves Maruoka asymmetric allylation and ring-cl